Edition:
United States

IRIDEX Corp (IRIX.OQ)

IRIX.OQ on NASDAQ Stock Exchange Global Market

15.23USD
12:23pm EST
Change (% chg)

$0.33 (+2.21%)
Prev Close
$14.90
Open
$14.93
Day's High
$15.23
Day's Low
$14.65
Volume
1,801
Avg. Vol
8,327
52-wk High
$16.50
52-wk Low
$7.51

IRIX.OQ

Chart for IRIX.OQ

About

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumenta... (more)

Overall

Beta: 1.13
Market Cap(Mil.): $151.21
Shares Outstanding(Mil.): 10.15
Dividend: --
Yield (%): --

Financials

  IRIX.OQ Industry Sector
P/E (TTM): -- 55.22 30.65
EPS (TTM): -0.05 -- --
ROI: -1.34 7.07 15.23
ROE: -1.37 10.66 16.56

BRIEF-Iridex reports 2016 third quarter, nine-month results

* Iridex Corp- continues to expect revenue growth for full year 2016 to be in low double-digits

Nov 03 2016

BRIEF-Iridex Q3 preliminary revenues of approximately $9.6 to $9.7 mln

* Iridex announces preliminary revenues for 2016 third quarter

Oct 11 2016

BRIEF-Iridex announces glaucoma efficacy data for micropulse P3 probe technology

* Iridex announces long-term glaucoma efficacy data for patients treated with micropulse P3 probe technology Source text for Eikon: Further company coverage:

Sep 07 2016

BRIEF-Iridex sees Q3 revenue $11 million to $11.3 million

* Company continues to expect revenue growth for full year 2016 to be in low double-digits

Aug 04 2016

BRIEF-Iridex names Chief Financial Officer

* Iridex announces Atabak Mokari will be chief financial officer and VP corporate development Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jul 11 2016

Earnings vs. Estimates